American Society of Hematology

Figure 2

$Figure 2. GPR56 expression is associated with poor outcome and specific genetic lesions. (A) Scatterplot displaying GPR56 and CD34 expression (log10 scale) in 437 AML samples from the Leucegene sample collection. Adjacent text indicates enrichment of sample parameters in the 4 highlighted quadrants. Quadrants are defined by RPKM values below and above the medians of CD34 and GPR56 (dashed lines). Enrichment was calculated with Fisher’s exact test. Adv., adverse; Chr, chromosome; CR, complete remission; NK = normal karyotype; OS = overall survival; Rel/Ref, relapse/refractory. (B) RPKM values of GPR56 in 22 paired diagnosis-relapse samples (P = .01, Wilcoxon matched pairs signed-rank test).$

GPR56 expression is associated with poor outcome and specific genetic lesions. (A) Scatterplot displaying GPR56 and CD34 expression (log10 scale) in 437 AML samples from the Leucegene sample collection. Adjacent text indicates enrichment of sample parameters in the 4 highlighted quadrants. Quadrants are defined by RPKM values below and above the medians of CD34 and GPR56 (dashed lines). Enrichment was calculated with Fisher’s exact test. Adv., adverse; Chr, chromosome; CR, complete remission; NK = normal karyotype; OS = overall survival; Rel/Ref, relapse/refractory. (B) RPKM values of GPR56 in 22 paired diagnosis-relapse samples (P = .01, Wilcoxon matched pairs signed-rank test).

This Feature Is Available To Subscribers Only